| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22 | 22 | 22 | 22 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 22 | 22 | 22 | 22 | | | Operating Expenses | | Research Development | 9,592 | 13,256 | 15,731 | 17,526 | | Selling General and Administrative | 4,592 | 4,297 | 3,365 | 4,602 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (14,162) | (17,531) | (19,074) | (22,106) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 47 | 83 | 165 | 315 | | Earnings Before Interest And Taxes | (14,115) | (17,448) | (18,909) | (21,791) | | Interest Expense | 318 | 358 | 394 | 335 | | Income Before Tax | (14,433) | (17,806) | (19,303) | (22,126) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,433) | (17,806) | (19,303) | (22,126) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,433) | (17,806) | (19,303) | (22,126) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,433) | ($17,806) | ($19,303) | ($22,126) |
|
0.22% Nasdaq 
Income Statement
